Business Standard Our focus is to be a relevant player in a consolidated market: Strides Founder

Read More >>

Strides Arcolab: Healthy product pipeline Recent rise in share price factors in some of the gains despite multiple growth drivers

Read More >>

Strides Arcolab Generic Coverage Update Direct Coverage Update 07.06.2012 in Business World

Read More >>

Strides margin to improve on Ascent sale Deal proceeds will help deleverage balance sheet and invest in fast growing specialty injectibles business.

Read More >>

Strides in Outlook Profit In 2010, Bangalorebased Strides Arcolab was chosen as Pfi zer's preferred partner. Earlier, in 2008, GlaxoSmith- Kline chose Strides to be its preferred partner. To get such a stamp of approval.

Read More >>

Exclusive Interview: Pfizer's global off-patent boss, David Simmons Exclusive Interview: Pfizer's global off-patent boss, David Simmons David Simmons is Pfizer's global President and General Manager, Established Products. He speaks exclusively to Pharma in Focus..

Read More >>

Multi Directional Growth Multi Directional Growth: The growth in the biologics and oncology segments, penetration of health insurance, government support and the need for more efficacious products will set the wheels turning..

Read More >>

A New Formula Andrew Wittythe 46 yr old Chief Executive Officer of GlaxSmithKline (GSK) has visited India twice during his two-year stint at the helm of the Wolrd's third-largest drug maker by sales. His predecessors were..

Read More >>